Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

A decision is expected in the fourth quarter of 2025.

Researchers believe nearly 25,000 hospital visits occurred, mostly due to gastrointestinal complications A new study analyzed ...

Rybelsus. Rybelsus is an oral form of semaglutide. It’s FDA-approved for diabetes, but (like Ozempic) it’s sometimes prescribed off-label for weight loss. Compounded semaglutide. Compounded ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Rybelsus. Rybelsus is a daily pill FDA-approved for diabetes but sometimes prescribed off-label for weight loss. As with brand-name versions of semaglutide, there’s no magic number for how long ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...